masoprocol and Fatty Liver, Nonalcoholic

masoprocol has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arshad, S; Azhar, S; Bittner, S; Cortez, Y; Dong, D; Dulay, H; Han, L; Kraemer, FB; Shen, WJ	1

Other Studies

1 other study(ies) available for masoprocol and Fatty Liver, Nonalcoholic

Article	Year
Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). Molecular and cellular endocrinology, 2019, 12-01, Volume: 498 Topics: Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Hyperlipidemias; Inflammation; Insulin Resistance; Larrea; Lipogenesis; Male; Masoprocol; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress	2019

Article

Year

Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH).

Molecular and cellular endocrinology, 2019, 12-01, Volume: 498

Topics: Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Hyperlipidemias; Inflammation; Insulin Resistance; Larrea; Lipogenesis; Male; Masoprocol; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress

2019